Status:
COMPLETED
Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma
Lead Sponsor:
CHU de Quebec-Universite Laval
Collaborating Sponsors:
Cancer Research Society
Conditions:
Ovarian Carcinoma
Eligibility:
FEMALE
Phase:
PHASE2
Brief Summary
Green tea is extracted from steam treated leaves, allowing the preservation of catechins, the active elements of the infusion. Catechins are recognized for their anti-cancer activity. Catechins act on...
Eligibility Criteria
Inclusion
- patients with ovarian serous carcinoma FIGO stage III or IV
- patients showing complete response after oncological surgery and chemotherapy (paclitaxel-carboplatin, minimum 5 cycles, maximum 8 cycles), complete response being defined as 1) a negative complete physical examination 2) Serum CA-125 levels inferior to 35 U/mL 3) no evidence of diseased assessed by abdomino-perineal CT-scan
- patients refraining from drinking tea other than provided by the study
- patients who may absorb liquids orally
- patients without any other malignancy (except for non-melanoma skin cancer)
- patients not involved in an other study
- patients who signed up informed consent form.
Exclusion
- exclusion criteria are implicit from inclusion criteria.
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00721890
Start Date
June 1 2008
End Date
June 1 2013
Last Update
October 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Québec, Hôtel-Dieu de Québec
Québec, Quebec, Canada, G1R 2J6